IP Library Granted Patent US 12,361,821
Granted Patent B2
US 12,361,821 · App. 17/820,443 · Granted Jul 15, 2025

Continuous patient monitoring

Inventors: WonKyung McSweeney (Manlius, NY); Stacey A. Fitzgibbons (Dewitt, NY); Thomas A. Gurgol (Clay, NY); David L. Kellner (Baldwinsville, NY); Christopher L. Long (Chittenango, NY); Rebecca Quilty-Koval (Baldwinsville, NY); Ching Yue Yeung (Fayetteville, NY)
Assignee: Welch Allyn, Inc.
G08B29/26G08B21/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,361,821
App. No.
17/820,443
Granted
Jul 15, 2025
Kind
B2
Abstract

A device for monitoring a physiological variable determines a starting value for a self-adjusting alarm limit based on an abnormal state of the physiological variable. The device determines a new value for the self-adjusting alarm limit from physiological data values received during a time window. When the new value for the self-adjusting alarm limit moves in a targeted direction, the device resets the self-adjusting alarm limit at the new value.

Claims (54)

1. A device for monitoring a physiological variable, comprising:

at least one processing device; and

a memory device storing instructions which, when executed by the at least one processing device, cause the device to:

determine a starting value for a self-adjusting alarm limit based on an abnormal state of the physiological variable;

receive a plurality of physiological data values from a physiological sensor during a time window;

determine a new value for the self-adjusting alarm limit based on a calculation of the plurality of physiological data values received during the time window;

when the new value for the self-adjusting alarm limit moves in a targeted direction, reset the self-adjusting alarm limit at the new value; and

wherein a length of the time window is adjustable to adjust a sensitivity level of the self-adjusting alarm limit.

2. The device of claim 1 , wherein the instructions further cause the device to:

when the new value for the self-adjusting alarm limit moves in a direction opposite of the targeted direction, trigger an alarm.

3. The device of claim 1 , wherein when the self-adjusting alarm limit is an upper alarm limit, the targeted direction is a decreasing targeted direction; and wherein when the self-adjusting alarm limit is a lower alarm limit, the targeted direction is an increasing targeted direction.

4. The device of claim 1 , wherein the new value for the self-adjusting alarm limit is based on a percentile calculated from the physiological data values received during the time window.

5. The device of claim 1 , wherein the new value for the self-adjusting alarm limit is based on a standard deviation of the physiological data values received during the time window.

6. The device of claim 1 , wherein the instructions further cause the device to:

determine an updated value for the self-adjusting alarm limit from physiological data values received during a subsequent time window;

when the updated value for the self-adjusting alarm limit moves in the targeted direction, reset the self-adjusting alarm limit at the updated value; and

when the updated value for the self-adjusting alarm limit moves in a direction opposite of the targeted direction, trigger an alarm.

7. The device of claim 6 , wherein the instructions further cause the device to:

determine a plurality of updated values for resetting the self-adjusting alarm limit during successive time windows until one or more exit criteria are satisfied.

8. The device of claim 7 , wherein the one or more exit criteria include a target value within a normal range of the physiological variable.

9. The device of claim 7 , wherein the one or more exit criteria include a time limit.

10. The device of claim 1 , wherein the instructions further cause the device to:

receive artifact data;

determine whether the artifact data exceeds a predetermined threshold amount; and

when the artifact data exceeds the predetermined threshold amount, exclude the physiological data values affected by the artifact data when determining the new value for the self-adjusting alarm limit, or alter a display of the physiological data values on a display device.

11. The device of claim 1 , wherein the instructions further cause the device to:

receive a treatment event;

determine an expected effect of the treatment event on the physiological data values; and

alter a display of the physiological data values based on the expected effect.

12. The device of claim 11 , wherein the physiological data values are displayed to include the treatment event and a modified range overlayed on the physiological data values, wherein the modified range has upper and lower limits based on the expected effect.

13. The device of claim 12 , wherein the upper and lower limits of the modified range are curves that show expected increases and decreases in the physiological data values.

14. The device of claim 13 , wherein the modified range is shaded differently based on where the modified range overlaps a normal range of the physiological data values.

15. A method of continuous physiological monitoring, comprising:

determining a starting value for a self-adjusting alarm limit based on an abnormal state of a physiological variable;

receiving a plurality of physiological data values from a physiological sensor during a time window;

determining a new value for the self-adjusting alarm limit based on a calculation of the plurality of physiological data values received during the time window;

resetting the self-adjusting alarm limit at the new value when the new value for the self-adjusting alarm limit moves in a targeted direction;

adjusting a length of the time window to adjust a sensitivity level of the self-adjusting alarm limit; and

triggering an alarm when the new value for the self-adjusting alarm limit moves in a direction opposite of the targeted direction.

16. The method of claim 15 , further comprising:

determining an updated value for the self-adjusting alarm limit from physiological data values received during a second time window;

resetting the self-adjusting alarm limit at the updated value when the updated value for the self-adjusting alarm limit moves in the targeted direction; and

triggering the alarm when the updated value for the self-adjusting alarm limit moves in a direction opposite of the targeted direction.

17. The method of claim 15 , further comprising:

receiving artifact data;

determining whether the artifact data exceeds a predetermined threshold amount; and

excluding the physiological data values affected by the artifact data when determining the new value for the self-adjusting alarm limit, or altering a display of the physiological data values when the artifact data exceeds the predetermined threshold amount.

18. The method of claim 15 , further comprising:

receiving a treatment event;

determining an expected effect on the physiological data values based on the treatment event, the expected effect being a targeted effect or a side effect; and

altering a display of the physiological data values based on the expected effect.

19. The method of claim 18 , further comprising:

displaying the treatment event overlayed on the physiological data values; and

displaying a modified range overlayed on the physiological data values, the modified range having upper and lower limits based on the expected effect of the treatment event.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 31, 2023
From: MCSWEENEY, WONKYUNG; FITZGIBBONS, STACEY A.; GURGOL, THOMAS A.; KELLNER, DAVID L.; LONG, CHRISTOPHER L.; QUILTY-KOVAL, REBECCA; YEUNG, CHING YUE
To: WELCH ALLYN, INC.
Reel/Frame 064437/0596 →
Continuity (2)
Provisional Application 63237758 · Aug 27, 2021
Related Publication 20230063782A1 · Mar 2, 2023
References Cited (66)
US 5438983A · Falcone · 1995 [cited by applicant]
US 5724025A · Tavori · 1998 [cited by examiner]
US 6024699A · Surwit · 2000 [cited by examiner]
US 6081742A · Amano et al. · 2000 [cited by applicant]
US 6241661B1 · Schluess et al. · 2001 [cited by applicant]
US 6890304B1 · Amano · 2005 [cited by examiner]
US 7052472B1 · Miller · 2006 [cited by applicant]
US 7066883B2 · Schmidt · 2006 [cited by examiner]
US 8028694B2 · Hickle · 2011 [cited by applicant]
US 8275553B2 · Ochs · 2012 [cited by examiner]
US 8690771B2 · Wekell · 2014 [cited by examiner]
US 8956292B2 · Wekell et al. · 2015 [cited by applicant]
US 9636056B2 · Al-Ali · 2017 [cited by applicant]
US 9636070B2 · Kassem et al. · 2017 [cited by applicant]
US 9724024B2 · Al-Ali · 2017 [cited by examiner]
US 9867575B2 · Maani et al. · 2018 [cited by applicant]
US 10052072B2 · Tsugo · 2018 [cited by applicant]
US 10098591B2 · Al-Ali et al. · 2018 [cited by applicant]
US 10264982B2 · Ahmed et al. · 2019 [cited by applicant]
US 10265030B2 · Johnson et al. · 2019 [cited by applicant]
US 10485488B2 · Bhat et al. · 2019 [cited by applicant]
US 10638937B2 · Ma et al. · 2020 [cited by applicant]
US 10674938B2 · Perez De Alejo Fortun · 2020 [cited by applicant]
US 10702174B2 · Fasciano · 2020 [cited by applicant]
US 10827961B1 · Iyengar · 2020 [cited by examiner]
US 10891766B1 · Gough et al. · 2021 [cited by applicant]
US 10925522B2 · Chang · 2021 [cited by examiner]
US 10976908B2 · Freeman et al. · 2021 [cited by applicant]
US 20020169366A1 · Schmidt · 2002 [cited by examiner]
US 20040230105A1 · Geva · 2004 [cited by examiner]
US 20050010447A1 · Miyasaka et al. · 2005 [cited by applicant]
US 20050177096A1 · Bollish et al. · 2005 [cited by applicant]
US 20070232867A1 · Hansmann · 2007 [cited by examiner]
US 20080086035A1 · Messerges · 2008 [cited by examiner]
US 20090043182A1 · Brauker · 2009 [cited by examiner]
US 20090210163A1 · Ochs · 2009 [cited by examiner]
US 20110213212A1 · Al-Ali · 2011 [cited by examiner]
US 20110245688A1 · Arora · 2011 [cited by applicant]
US 20110301436A1 · Teixeira · 2011 [cited by examiner]
US 20120016255A1 · Masuo · 2012 [cited by applicant]
US 20120116194A1 · Gross · 2012 [cited by examiner]
US 20120277545A1 · Teixeira · 2012 [cited by examiner]
US 20120330565A1 · Ochs · 2012 [cited by examiner]
US 20140266786A1 · Sugiyama · 2014 [cited by examiner]
US 20150077268A1 · Lane et al. · 2015 [cited by applicant]
US 20160155309A1 · Watson · 2016 [cited by examiner]
US 20160163187A1 · Treacy · 2016 [cited by examiner]
US 20160220197A1 · Rantala · 2016 [cited by applicant]
US 20170202469A1 · Scharf et al. · 2017 [cited by applicant]
US 20170225336A1 · Deyle · 2017 [cited by examiner]
US 20180078219A1 · Selvaraj · 2018 [cited by examiner]
US 20190142343A1 · Emmons et al. · 2019 [cited by applicant]
US 20190164633A1 · Ingel et al. · 2019 [cited by applicant]
US 20190183354A1 · Rowe · 2019 [cited by applicant]
US 20190246966A1 · Friedman · 2019 [cited by examiner]
US 20200121199A1 · Freeman et al. · 2020 [cited by applicant]
US 20200261009A1 · Everman · 2020 [cited by examiner]
US 20200273581A1 · Wolf · 2020 [cited by examiner]
US 20200335190A1 · Chung et al. · 2020 [cited by applicant]
US 20210015425A1 · Clift-Reaves et al. · 2021 [cited by applicant]
US 20230190209A1 · McSweeney · 2023 [cited by examiner]
WO 2011116340A2 · 2011 [cited by applicant]
WO 2014140978A1 · 2014 [cited by applicant]
WO 2017221745A1 · 2017 [cited by applicant]
WO 2020197903A1 · 2020 [cited by applicant]
Extended European Search Report for Application No. 22192115.8 mailed Jan. 5, 2023. [cited by applicant]